Related Experiment Video
Updated: May 30, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.6K
Dose Accuracy and Reliability of a Connected Insulin Pen System
Matthew Backfish1, Kimberly Kovalchick1, Robert Albert1
1Eli Lilly and Company, Indianapolis, IN, USA.
Journal of Diabetes Science and Technology
|January 30, 2025
Summary
The Tempo Pen system with its Smart Button accurately delivers insulin doses and reliably records injection data, meeting international standards for diabetes care.
Area of Science:
- Medical Devices
- Diabetes Technology
- Pharmaceutical Engineering
Background:
- Insulin pen injection therapy is crucial for diabetes management.
- Dose accuracy and reliability are critical for effective insulin therapy.
- The Tempo Pen system with Tempo Smart Button aims to enhance insulin delivery.
Purpose of the Study:
- To evaluate the dose accuracy of the Tempo Pen system.
- To assess the reliability of the Tempo Smart Button in data detection, storage, and transmission.
- To ensure compliance with International Organization for Standardization (ISO) standards.
Main Methods:
- Testing the Tempo Pen system with the Tempo Smart Button under standard atmospheric conditions.
- Evaluating three specific insulin doses for accuracy.
- Assessing the Module's performance in detecting, storing, and transmitting dose data.
- Comparing results against ISO 11608-1:2014 requirements.
Main Results:
- The Tempo Pen system met ISO 11608-1:2014 requirements for dose accuracy across all tested doses.
- Mean doses delivered were 0.010 mL (0.002 mL SD), 0.299 mL (0.002 mL SD), and 0.597 mL (0.004 mL SD).
- The Smart Button Module successfully met data transfer requirements after each injection.
Conclusions:
- The Tempo Pen system demonstrates accurate insulin dose delivery.
- The integrated Smart Button reliably captures and stores essential insulin dosing information.
- The system provides a dependable solution for insulin injection therapy in diabetes management.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
141
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
141
Insulin Formulations: Types and Delivery
162
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
162
Errors occurring during blood pressure monitoring
588
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
588

